v3.25.4
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities:    
Loss from continuing operations $ (11,870,000) $ (24,770,000)
Adjustments to reconcile loss from operations to net cash used by operating activities:    
Depreciation and amortization 1,145,000 1,119,000
Stock based compensation 13,000 19,000
Issuance of shares for professional services rendered 190,000  
Accrued interest on notes payable 793,000 1,065,000
Change in deferred tax liability (2,580,000) 33,000
Change in fair value of note payable, related party 9,388,000 (5,068,000)
Impairment of inventory 419,000  
Loss on disposal of fixed assets 12,000
Impairment of fixed assets 263,000
Impairment of goodwill 25,093,000
Decrease (increase) in assets:    
Accounts receivable (1,000) 128,000
Inventory 7,000
Prepaid expenses and other current assets 126,000 (265,000)
Increase (decrease) in liabilities:    
Accounts payable 470,000 (436,000)
Accrued expenses (2,000) (35,000)
Net cash used operating activities (1,890,000) (2,854,000)
Cash flows from investing activities:    
Payments received on notes receivable 3,000 2,000
Net cash provided by investing activities 3,000 2,000
Cash flows from financing activities:    
Borrowings from related party 184,000
Payments to related party (293,000)
Borrowings of note payable, related party 1,124,000
Issuances of common stock, net of issuance costs 3,726,000
Net cash (used) provided by financing activities (109,000) 4,850,000
Net increase (decrease) in cash (1,996,000) 1,998,000
Cash and cash equivalents at beginning of year 1,999,000 1,000
Cash and cash equivalents at end of year $ 3,000 $ 1,999,000